TAMPA, Fla.--(BUSINESS WIRE)--The clinical results of an IRB-approved prospective, multi-center phase II, non-randomized pilot study utilizing the DRX9000™ will be presented by two of its authors at the Parker Seminars Las Vegas February 7 – 9, 2008. The study, authored by Dr. John Leslie of The Mayo Clinic and others, was designed to evaluate the effectiveness and safety of the DRX9000 in the treatment of chronic lower back pain. Patients enrolled in the study had suffered an overall average of ten years of chronic back pain. After two weeks of treatment on the DRX9000 there was an average 50% reduction in pain scores and upon completion of the entire six week protocol an amazing success rate of 88.9% was documented. The investigators also noted an improvement in Oswestry Disability score.
